https://www.selleckchem.com/pr....oducts/leupeptin-hem
8% and 80.4%, respectively. Multivariate analysis found that tumor size and the route of lymph node removal were independent prognostic factors for recurrence. When LRH was first introduced into Japan, we found that the route of lymph node removal was an independent prognostic factor for recurrence in addition to large tumors (≥ 2cm). Our results suggest that prognosis may be secured by paying attention to the lymph node removal route. When LRH was first introduced into Japan, we found that the route of lymph node removal